Edmonton, Canada

Ashish S Paradkar

This inventor holds 4 USPTO granted patents. Top assignees: University of Alberta, Other. Active years: 2001-2003.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2001-2003

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Ashish S Paradkar: Innovator in Clavulanic Acid Biosynthesis

Introduction

Ashish S Paradkar is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of biotechnology, particularly in the biosynthesis of clavulanic acid. With a total of 4 patents to his name, Paradkar's work has implications for antibiotic development and production.

Latest Patents

Among his latest patents, Paradkar has developed DNA sequences that encode the enzymes required for clavulanic acid synthesis. These innovations include a process for producing clavulanic acid in a transformant of a non-clavulanate-producing host. This advancement is crucial for enhancing the efficiency of clavulanic acid production, which is an important compound in the pharmaceutical industry.

Career Highlights

Throughout his career, Ashish S Paradkar has been associated with the University of Alberta, where he has contributed to various research initiatives. His work has not only advanced scientific understanding but has also paved the way for practical applications in medicine.

Collaborations

Paradkar has collaborated with esteemed colleagues such as Kwamena A Aidoo and Susan E Jensen. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Ashish S Paradkar's innovative work in the field of clavulanic acid biosynthesis exemplifies the importance of research and development in biotechnology. His contributions continue to influence the pharmaceutical landscape, showcasing the vital role of inventors in advancing science and technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…